Clinical Trial: A prospective, single-arm, single-center clinical study on the neoadjuvant treatment of locally advanced MSS-type colon cancer with low methylation of PD-L1 K162 using envelone (PD-L1) combined with XELOX. (China)

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, single-arm, single-center clinical study on the neoadjuvant treatment of locally advanced MSS-type colon cancer with low methylation of PD-L1 K162 using envelone (PD-L1) combined with XELOX.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130693

Registration Time: 2026/08/24

Type: Interventional study

Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=304343

Published by HT Digital Content Services with permission from Health Daily Diges...